Issue link: https://www.e-digitaleditions.com/i/1469783
Inhalation June 2022 21 Fully integrated development and manufacturing Recipharm offers a fully integrated service for devel- oping and manufacturing inhalation drug products and devices for the global pharmaceutical market, including pressurized metered dose inhalers (pMDIs), soft mist inhalers (SMIs), dry powder inhalers (DPIs), unit-dose and multi-dose nasal sprays. Recipharm has a long history of supplying inhalation products to the market. By considering commercial manufacturing from the outset, we minimize hurdles during devel- opment and reduce time to market. Recipharm Sweden: +46 8 602 52 00 www.recipharm.com Fully walk away nasal system e Indizo ® system is a fully walk away platform that automates the labor-intensive and error-prone tasks of spraying, weighing and sample collection for pump delivery and dose content uniformity testing for vertically and side-actuated nasal sprays. Using Vereo ® Actuator technology as its core engine and Viota ® software for control and analysis, the sys- tem reduces out-of-specification results and manual inconsistencies with precise, repeatable actuation, offering a superior level of parameter control to mimic human usage. Proveris Scientific US: +1 508 460-8822 contactus@proveris.com www.proveris.com Nasal formulation development and manufacturing Renaissance Lakewood offers contract development and manufacturing for nasal sprays. We can support all stages of projects, from formulation development through commercial manufacturing. With over 20 years of experience, our team can support a wide range of development activities including formulation development/optimization, spray method develop- ment, device selection, clinical trial material, process development and stability studies. In addition, we can support a wide range of nasal spray devices, includ- ing unit-dose, bi-dose and multi-dose (preserved and non-preserved formulations). Renaissance Lakewood US: +1 732 367-9000 www.renpharm.com